Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-43.58%Return on Equity
VS
Market
Sector
Industry
History
$ 3.04Close
$ 0.42 - $ 4.74 52-Week Range
Ticker Information
Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABVC BIOPHARMA INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABVC - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 7.01M | $ -3.06M | -43.58% |
| 3/31/2025 | $ 5.4M | $ -1.81M | -33.53% |
| 12/31/2024 | $ 1.23M | $ -4.9M | -399.86% |
| 9/30/2024 | $ 8.36M | $ -8.24M | -98.62% |
| 6/30/2024 | $ 8.29M | $ -11.37M | -137.15% |
| 3/31/2024 | $ 7.79M | $ -12.62M | -162.02% |
| 12/31/2023 | $ 8.39M | $ -10.52M | -125.36% |
| 9/30/2023 | $ 9.1M | $ -12.27M | -134.82% |
| 6/30/2023 | $ -379.31K | $ -12.66M | 0% |
| 3/31/2023 | $ 1.67M | $ -12.25M | -733.41% |
Key Performance Insights, Last 5 Years
- ABVC BIOPHARMA INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, ABVC BIOPHARMA INC's average ROE has been -235.7%.
- The median ROE for ABVC BIOPHARMA INC during this period was -153.6%
- ABVC BIOPHARMA INC reached its highest ROE over the past 5 years at -33.53%.
- The lowest ROE recorded by ABVC BIOPHARMA INC in the same timeframe -733.41%
ABVC BIOPHARMA INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ABVC BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 2.57M ]
(=) ROE [ 0% ] ABVC - Return on Equity, Last 5 years
-733.41%
Minimum
Mar 31, 2023
-33.53%
Maximum
Mar 31, 2025
-235.7%
Average
-153.6%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |